Select Medical Corporation Signs Agreement to Acquire SemperCare, Inc.

Article

MECHANICSBURG, Pa. -- Select Medical Corporation today announced the signing of a definitive agreement to acquire SemperCare, Inc., a privately held company based in Plano, Texas, for approximately $100 million in cash.  The purchase price is subject to

adjustment based on SemperCare's net working capital on the closing date.

   

SemperCare operates 17 long-term acute care hospitals in 11 states.

SemperCare's revenues for calendar 2003 and the nine months ended

September 30, 2004 were approximately $83.0 million and $110.6 million,

respectively.  The transaction, which is expected to close in the first

quarter of 2005, is subject to a number of closing conditions, including

receipt of regulatory approvals.  Robert A. Lefton, SemperCare's co-founder,

president and CEO, and Gary A. Kagan, SemperCare's

co-founder and executive vice president of development, will remain with

SemperCare as employees after the transaction is completed.

 

Select Medical Corporation is a leading operator of specialty hospitals in

the United States.  Select operates 82 long-term acute care hospitals in

25 states.  Select operates four acute medical rehabilitation hospitals in New

Jersey.  Select is also a leading operator of outpatient rehabilitation

clinics in the United States and Canada, with approximately 750 locations.

Select also provides medical rehabilitation services on a contract basis at

nursing homes, hospitals, assisted living and senior care centers, schools and

worksites. 

 

  

Source: Select Medical Corporation

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
Jill Holdsworth, MS, CIC, FAPIC, NREMT, CRCST, CHL, an infection preventionist from Atlanta, Georgia.  (Photo credit: Tori Whitacre Martonicz)
"Top 5" in a blue ribbon  (Adobe Stock 235182652 by Evgeny)
Bug of the Month
© 2025 MJH Life Sciences

All rights reserved.